These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2211211)

  • 1. Drug resistance following irradiation of RIF-1 tumors: influence of the interval between irradiation and drug treatment.
    Hopwood LE; Davies BM; Moulder JE
    Int J Radiat Oncol Biol Phys; 1990 Sep; 19(3):643-50. PubMed ID: 2211211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation induction of drug resistance in RIF-1 tumors and tumor cells.
    Hopwood LE; Moulder JE
    Radiat Res; 1989 Nov; 120(2):251-66. PubMed ID: 2616741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation induction of drug resistance in RIF-1: correlation of tumor and cell culture results.
    Moulder JE; Hopwood LE; Volk DM; Davies BM
    Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):213-6. PubMed ID: 1991681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of established tumors and induction of tumor immunity by intratumor chemotherapy.
    Bast RC; Segerling M; Ohanian SH; Greene SL; Zbar B; Rapp HJ; Borsos T
    J Natl Cancer Inst; 1976 Apr; 56(4):829-32. PubMed ID: 176411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1 modulatory effect on the action of chemotherapeutic drugs and localized irradiation of the lip, duodenum, and tumor.
    Zaghloul MS; Dorie MJ; Kallman RF
    Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):417-25. PubMed ID: 8514539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of tumor radiation response by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid.
    Wilson WR; Li AE; Cowan DS; Siim BG
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):905-8. PubMed ID: 9845119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological modulation of photodynamic therapy with hematoporphyrin derivative and light.
    Cowled PA; Mackenzie L; Forbes IJ
    Cancer Res; 1987 Feb; 47(4):971-4. PubMed ID: 2948637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effect of clinically relevant doses of emitefur, a new 5-fluorouracil derivative, and radiation in murine tumours.
    Shibamoto Y; Murata R; Miyauchi S; Hirohashi M; Takagi T; Sasai K; Shibata T; Oya N; Takahashi M
    Br J Cancer; 1996 Dec; 74(11):1709-13. PubMed ID: 8956782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of the frequency of methotrexate resistance by gamma-radiation in Chinese hamster ovary and mouse 3T6 cells.
    Sharma RC; Schimke RT
    Cancer Res; 1989 Jul; 49(14):3861-6. PubMed ID: 2736529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro.
    Dempke WC; Shellard SA; Hosking LK; Fichtinger-Schepman AM; Hill BT
    Carcinogenesis; 1992 Jul; 13(7):1209-15. PubMed ID: 1638688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evaluation of a novel antitumor prodrug, 1-(2'-oxopropyl)-5-fluorouracil (OFU001), which releases 5-fluorouracil upon hypoxic irradiation.
    Shibamoto Y; Zhou L; Hatta H; Mori M; Nishimoto SI
    Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):407-13. PubMed ID: 11173134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
    Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A
    Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of stromal sensitivity on radiation response of tumors.
    Budach W; Taghian A; Freeman J; Gioioso D; Suit HD
    J Natl Cancer Inst; 1993 Jun; 85(12):988-93. PubMed ID: 8496984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of variation in inherent sensitivities to radiation, 5-fluorouracil and methotrexate in a series of human and murine tumor cell lines in vitro.
    Bellamy AS; Whelan RD; Hill BT
    Int J Radiat Oncol Biol Phys; 1984 Jan; 10(1):87-93. PubMed ID: 6698828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of treatment in fractionated schedules with the combination of X-irradiation and six cytotoxic drugs on the RIF-1 tumor and normal mouse skin.
    Lelieveld P; Scoles MA; Brown JM; Kallman RF
    Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):111-21. PubMed ID: 4038500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of chemotherapeutic responsiveness in Nb rat prostate cancer model. 5-fluorouracil, methotrexate, cyclophosphamide, and adriamycin.
    Drago JR; Goldman L; Gershwin ME
    Invest Urol; 1980 Jul; 18(1):80-1. PubMed ID: 7410017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apparent ineffectiveness of adriamycin for growth of androgen-dependent Shionogi carcinoma 115 in the mouse.
    Omukai Y; Watanabe S; Nohno T; Senoo T; Saito T
    Cancer Lett; 1983 Jan; 17(3):327-32. PubMed ID: 6831388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine L5178Y cells resulting in altered drug sensitivities from fractionated radiation exposure in vitro.
    Bellamy AS; Hill BT
    J Natl Cancer Inst; 1984 Feb; 72(2):411-7. PubMed ID: 6582326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of collateral sensitivity to cisplatin, methotrexate, and fluorouracil in a human ovarian carcinoma cell line following exposure to fractionated x-irradiation in vitro.
    Dempke WC; Hosking LK; Hill BT
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):66-72. PubMed ID: 1557659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy studies in autochthonous rat tumors. Forestomach and bladder cancer.
    Habs M; Ang J; Schmähl D
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1977 Jun; 89(2):119-36. PubMed ID: 70891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.